PRME: Prime Editing enables versatile, safe gene editing with key clinical and regulatory milestones ahead
Prime Editing technology offers broad, precise, and safe genome editing, with lead programs advancing in Wilson disease, Alpha-1, and CGD. The LNP platform enables rapid expansion across indications, and regulatory flexibility supports accelerated timelines. Cash runway extends into 2027.Based on P…